Innovative polatuzumab vedotin plus R-CHP therapy reshapes treatment of older adult patients with diffuse large B-cell lymphoma.

Along with this multi-pronged vector, patients will also receive immunomodulatory molecules such as granulocyte–macrophage colony-stimulating factor and interferon, which could make T cells more ...

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced ...

LANGHORNE, Pa.--(BUSINESS WIRE)-- Savara Inc. (SVRA) (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards ...